Sequent Scientific Limited has informed the Exchange about General Updates
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sequent Scientific has informed the exchanges that its Board has approved the re-appointment of Dr. Kamal Sharma (DIN: 00209430) and Mr. Milind Sarwate (DIN: 00109854) as Non-Executive Independent Directors for a second term of five consecutive years, from August 25, 2025 to August 24, 2030. The decision is subject to shareholder approval. Dr. Sharma is a former Managing Director of Lupin with over five decades of experience in the chemical and pharmaceutical industries. Mr. Sarwate is the founder of Increate and serves on boards of companies such as Asian Paints, Mahindra Finance, CEAT, Nykaa, and Hexaware, with 42 years of experience as a former CFO and CHRO at Marico and Godrej. Neither director is related to any other board member and both are eligible under SEBI norms.
This is a routine corporate governance update with no direct impact on financials or operations. Continuity of experienced independent directors may be viewed positively by shareholders as it signals board stability, though it requires shareholder approval.